Grufity logoGrufity logo
StocksFundsSearch FilingsAPI

Merit Medical Systems Inc Stock Research

MMSI

69.18USD+0.56(+0.82%)Market Closed
Watchlist

Market Summary

USD69.18+0.56
Market Closed
0.82%

MMSI Alerts

  • 1 major insider sales recently.

MMSI Stock Price

MMSI RSI Chart

MMSI Valuation

Market Cap

4.0B

Price/Earnings (Trailing)

44.49

Price/Sales (Trailing)

3.33

EV/EBITDA

20.49

Price/Free Cashflow

82.2

MMSI Price/Sales (Trailing)

MMSI Profitability

EBT Margin

8.01%

Return on Equity

7.23%

Return on Assets

5.03%

Free Cashflow Yield

1.22%

MMSI Fundamentals

MMSI Revenue

Revenue (TTM)

1.2B

Revenue Y/Y

8.5%

Revenue Q/Q

7.56%

MMSI Earnings

Earnings (TTM)

89.6M

Earnings Y/Y

32.34%

Earnings Q/Q

-2.21%

Price Action

52 Week Range

52.7985.62
(Low)(High)

Last 7 days

4.6%

Last 30 days

1.8%

Last 90 days

-16.3%

Trailing 12 Months

20.9%

MMSI Financial Health

Current Ratio

2.58

Debt/Equity

0.19

Debt/Cashflow

0.53

MMSI Investor Care

Shares Dilution (1Y)

1.66%

Diluted EPS (TTM)

1.56

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales

Latest Insider Trading transactions for MMSI

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2023-08-25
LAMPROPOULOS FRED P
sold (taxes)
-9,094,570
67.19
-135,356
president and ceo
2023-08-25
LAMPROPOULOS FRED P
sold (taxes)
-245,915
67.19
-3,660
president and ceo
2023-08-25
LAMPROPOULOS FRED P
acquired
5,640,000
28.2
200,000
president and ceo
2023-08-25
LAMPROPOULOS FRED P
acquired
169,200
28.2
6,000
president and ceo
2023-08-22
Peterson Neil
acquired
225,600
28.2
8,000
chief operating officer
2023-08-22
Peterson Neil
sold
-543,288
67.911
-8,000
chief operating officer
2023-08-14
ANDERSON A SCOTT
gifted
-
-
-2,820
-
2023-08-09
ANDERSON A SCOTT
acquired
1,262,500
50.5
25,000
-
2023-08-09
ANDERSON A SCOTT
sold
-1,539,290
69.4
-22,180
-
2023-05-18
Ward Lynne
acquired
-
-
2,262
-

1–10 of 50

Which funds bought or sold MMSI recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2023-09-12
Farther Finance Advisors, LLC
new
-
1,422
1,422
-%
2023-08-22
VIRGINIA RETIREMENT SYSTEMS ET AL
added
1.53
215,016
1,664,440
0.02%
2023-08-22
COMERICA BANK
sold off
-
-
-
-%
2023-08-21
OSAIC HOLDINGS, INC.
added
82.4
1,162,290
2,255,850
-%
2023-08-21
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY
added
5.72
252,000
1,540,000
0.01%
2023-08-21
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
reduced
-1.89
574,402
5,810,140
0.01%
2023-08-18
Legato Capital Management LLC
new
-
433,255
433,255
0.06%
2023-08-16
CreativeOne Wealth, LLC
new
-
1,040,000
1,040,000
0.03%
2023-08-16
Nuveen Asset Management, LLC
added
0.97
5,987,770
48,167,800
0.02%
2023-08-16
CASTLEARK MANAGEMENT LLC
added
40.45
2,212,180
5,971,060
0.27%

1–10 of 50

Latest Funds Activity

Are funds buying MMSI calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own MMSI
No. of Funds

Schedule 13G FIlings of Merit Medical Systems

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 15, 2023
arrowmark colorado holdings llc
4.42%
2,517,226
SC 13G/A
Feb 09, 2023
william blair investment management, llc
6.6%
3,729,980
SC 13G/A
Feb 09, 2023
vanguard group inc
11.99%
6,824,344
SC 13G/A
Jan 26, 2023
blackrock inc.
17.0%
9,670,688
SC 13G/A
Jan 20, 2023
blackrock inc.
17.0%
9,670,688
SC 13G/A
Feb 14, 2022
arrowmark colorado holdings llc
5.51%
3,111,000
SC 13G/A
Feb 10, 2022
william blair investment management, llc
5.9%
3,357,638
SC 13G/A
Feb 10, 2022
vanguard group inc
10.16%
5,737,781
SC 13G/A
Jan 27, 2022
blackrock inc.
14.8%
8,334,516
SC 13G/A
Jan 25, 2022
blackrock inc.
14.8%
8,334,516
SC 13G/A

Recent SEC filings of Merit Medical Systems

View All Filings
Date Filed Form Type Document
Aug 29, 2023
4
Insider Trading
Aug 23, 2023
4
Insider Trading
Aug 14, 2023
4
Insider Trading
Aug 11, 2023
4
Insider Trading
Aug 09, 2023
144
Notice of Insider Sale Intent
Aug 07, 2023
144
Notice of Insider Sale Intent
Jul 28, 2023
10-Q
Quarterly Report
Jul 25, 2023
8-K
Current Report
Jun 29, 2023
11-K
Employee Benefit Details

Peers (Alternatives to Merit Medical Systems)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
111.5B
19.5B
5.69% 32.97%
41.17
5.73
10.36% 30.30%
105.3B
6.7B
4.79% 48.19%
73.87
15.8
11.75% -0.66%
76.7B
13.4B
5.66% 28.78%
84.09
5.72
8.69% 3.17%
71.3B
19.0B
-2.82% 6.66%
44.09
3.79
0.46% -5.24%
44.4B
5.7B
-4.65% -17.80%
31.95
7.85
5.64% -4.53%
MID-CAP
10.1B
937.8M
4.57% 35.10%
345.61
10.73
16.30% 250.21%
7.7B
616.6M
-5.28% -28.68%
31.46
12.45
69.52% 343.68%
5.3B
1.1B
-3.27% -11.90%
25.4
4.87
12.63% 50.85%
2.9B
452.1M
-15.03% -38.95%
-28.79
6.32
24.99% 24.09%
1.4B
790.3M
-24.48% -59.71%
-6.39
1.81
3.21% -1604.53%
SMALL-CAP
1.6B
421.8M
-7.15% 55.58%
-9.77
3.87
44.49% -2.43%
959.6M
780.7M
-7.16% -11.41%
-26.66
1.23
4.68% -510.17%
839.3M
239.8M
0.70% 0.15%
-22.16
3.5
-4.74% -31.15%
637.3M
162.9M
-22.73% -61.80%
-12.05
3.91
42.67% 12.82%

Merit Medical Systems News

Nasdaq
Should You Invest in the Invesco S&P SmallCap Health Care ETF ....
Nasdaq,
25 hours ago
Zacks Investment Research
StockNews.com
Simply Wall St

Returns for MMSI

Cumulative Returns on MMSI

18.5%


10-Year Cumulative Returns

16.2%


7-Year Cumulative Returns

2.6%


5-Year Cumulative Returns

17.9%


3-Year Cumulative Returns

Risks for MMSI

What is the probability of a big loss on MMSI?

72.3%


Probability that Merit Medical Systems stock will be more than 20% underwater in next one year

21.9%


Probability that Merit Medical Systems stock will be more than 30% underwater in next one year.

19.6%


Probability that Merit Medical Systems stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does MMSI drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Merit Medical Systems was unfortunately bought at previous high price.

Drawdowns

Financials for Merit Medical Systems

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Last 12 Months)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q2
Revenue2.1%1,1981,1731,1511,1361,1161,1011,0751,0541,0319699649649631,000995970949918883840798
Gross Profit3.3%554537519513505494485468449409401402404432432425423411395376354
Operating Expenses2.8%450438432434429432424413410398403423428424417393367352336318316
  S&GA Expenses4.4%364349343336333339336339325300298300315328327321300289276260248
  R&D Expenses-----------------62.0061.0060.0057.0055.00
EBITDA-100.0%-18317116015614314314012710291.0071.0069.0099.00107------
EBITDA Margin-100.0%-0.16*0.15*0.14*0.14*0.13*0.13*0.13*0.12*0.11*0.09*0.07*0.07*0.10*-------
Interest Expenses31.8%10.007.006.005.005.005.005.006.007.008.0010.0011.0012.0013.0012.0012.0011.0011.0010.0010.009.00
Earnings Before Taxes4.5%98.0094.0083.0073.0069.0055.0054.0047.0031.001.00-13.23-34.44-37.94-6.642.0022.0047.0050.0050.0049.0027.00
EBT Margin-100.0%-0.08*0.07*0.06*0.06*0.05*0.05*0.04*0.03*0.00*-0.01*-0.04*-0.04*-0.01*-------
Net Income5.8%90.0085.0075.0062.0058.0048.0048.0043.0028.004.00-9.84-29.43-29.81-3.905.0019.0039.0043.0042.0040.0019.00
Net Income Margin-100.0%-0.07*0.06*0.05*0.05*0.04*0.05*0.04*0.03*0.00*-0.01*-0.03*-0.03*0.00*-------
Free Cashflow-100.0%-69.0069.0091.0090.0093.0011910813513311910047.0019.00-0.36------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q2
Assets9.1%1,8381,6841,6641,6331,6321,6301,6481,6431,6421,6521,6641,6711,7161,7491,7571,7621,7361,6901,6201,3101,291
  Current Assets6.8%595557529500493478482463450438430435446463455441427422430388371
    Cash Equivalents24.4%72.0058.0058.0051.0063.0054.0068.0069.0070.0059.0057.0045.0050.0050.0044.0037.0035.0050.0067.0052.0044.00
  Inventory5.7%306290266247233231222208195200198209221228226217203199198181169
  Net PPE-0.8%384387383376371372372373374378383384384385379367351341331320312
  Goodwill6.0%382360360358360361362362363363364354353352353352352335335--
Liabilities23.7%634512520544558573608630650675706737787809807812786750687387592
  Current Liabilities-12.0%190216221213196204236213211208185186174165182153177178175140140
    LT Debt, Current-66.7%4.0011.0011.0011.0010.009.008.008.008.008.008.008.008.008.008.008.0015.0022.0022.0022.0022.00
    LT Debt, Non Current79.8%335186187205236243234271285313344350403438432432385362373187392
Shareholder's Equity2.7%1,2041,1721,1441,0891,0731,0571,0401,013992977959934929940950949951940933923699
  Retained Earnings4.0%522501481447432417406386374369358342345364368373377370363354338
Accumulated Depreciation2.6%320311303300294288281277273266261255248239232230222215210204198
Shares Outstanding0.3%58.0057.0057.0057.0057.0057.0057.0056.0056.0056.0056.0056.0055.0055.0055.0055.0055.0055.0055.0053.0050.00
Cashflow (Last 12 Months)
(In Millions)
Cashflow (Last 12 Months)
(In Millions)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q2
Cashflow From Operations-18.4%95.0011711413212212414713816817216515511593.0078.0075.0087.0092.0087.0082.0063.00
  Share Based Compensation6.5%18.0017.0018.0018.0018.0017.0016.0016.0015.0015.0014.0013.0011.0010.009.009.008.007.006.006.005.00
Cashflow From Investing-207.5%-191-62.38-57.40-54.67-45.20-40.68-37.16-44.42-46.50-50.24-58.65-57.35-87.10-128-134-309-291-282-378-194-235
Cashflow From Financing332.6%108-46.52-60.26-86.98-77.80-86.43-98.43-70.51-104-115-95.71-91.32-13.4137.0034.00222198209328141177

MMSI Income Statement

2023-06-30
CONSOLIDATED STATEMENTS OF INCOME - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Income Statement [Abstract]    
Net sales$ 320,056$ 294,976$ 617,621$ 570,391
Cost of sales167,274159,909326,477314,417
Gross profit152,782135,067291,144255,974
Operating expenses:    
Selling, general and administrative100,92785,487191,071169,502
Research and development20,12918,46641,44335,853
Impairment charges270 2701,672
Contingent consideration expense1,0941,1871,6153,787
Acquired in-process research and development1,5506,6711,5506,671
Total operating expenses123,970111,811235,949217,485
Income from operations28,81223,25655,19538,489
Other income (expense):    
Interest income22196352201
Interest expense(3,682)(1,348)(5,693)(2,350)
Other income (expense) - net(451)(1,303)546(1,468)
Total other expense - net(3,912)(2,555)(4,795)(3,617)
Income before income taxes24,90020,70150,40034,872
Income tax expense4,6555,4039,4529,029
Net income$ 20,245$ 15,298$ 40,948$ 25,843
Earnings per common share    
Basic (in dollars per share)$ 0.35$ 0.27$ 0.71$ 0.46
Diluted (in dollars per share)$ 0.35$ 0.27$ 0.70$ 0.45
Weighted average shares outstanding    
Basic (in shares)57,53756,69157,44556,642
Diluted (in shares)58,47357,60058,32957,565

MMSI Balance Sheet

2023-06-30
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Current assets:  
Cash and cash equivalents$ 72,084$ 58,408
Trade receivables - net of allowance for credit losses - 2023 - $8,652 and 2022 - $8,423170,990164,677
Other receivables12,63412,992
Inventories305,943265,991
Prepaid expenses and other current assets24,97122,324
Prepaid income taxes3,9203,913
Income tax refund receivables4,365779
Total current assets594,907529,084
Property and equipment:  
Land and land improvements26,01725,940
Buildings189,900189,148
Manufacturing equipment306,925299,089
Furniture and fixtures66,04661,128
Leasehold improvements52,60449,673
Construction-in-progress62,37461,269
Total property and equipment703,866686,247
Less accumulated depreciation(319,504)(303,271)
Property and equipment - net384,362382,976
Other assets:  
Goodwill381,767359,821
Deferred income tax assets6,4926,599
Right-of-use operating lease assets62,43665,262
Other assets52,49244,352
Total other assets858,299751,906
Total assets1,837,5681,663,966
Current liabilities:  
Trade payables61,76168,504
Accrued expenses110,662123,189
Current portion of long-term debt3,75011,250
Short-term operating lease liabilities11,53111,005
Income taxes payable2,2996,697
Total current liabilities190,003220,645
Long-term debt335,232186,759
Deferred income tax liabilities18,47718,462
Long-term income taxes payable347347
Liabilities related to unrecognized tax benefits1,9121,912
Deferred compensation payable16,41815,264
Deferred credits1,6571,708
Long-term operating lease liabilities56,59959,736
Other long-term obligations13,22314,736
Total liabilities633,868519,569
Commitments and contingencies
Stockholders' equity:  
Preferred stock - 5,000 shares authorized as of June 30, 2023 and December 31, 2022; no shares issued
Common stock, no par value; 100,000 shares authorized; issued and outstanding as of June 30, 2023 - 57,634 and December 31, 2022 - 57,306691,523675,174
Retained earnings521,721480,773
Accumulated other comprehensive loss(9,544)(11,550)
Total stockholders' equity1,203,7001,144,397
Total liabilities and stockholders' equity1,837,5681,663,966
Developed technology  
Other assets:  
Intangible assets309,228237,522
Other  
Other assets:  
Intangible assets$ 45,884$ 38,350
Fred P. Lampropoulos
6450
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments, Cardiovascular and Endoscopy. It provides peripheral intervention products for the diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. The company also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coated tubes and wires; and sensor components for microelectromechanical systems. In addition, it provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate strictures; gastroenterology products; and kits and accessories for endoscopy and bronchoscopy procedures. The company sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers in the United States and internationally. Merit Medical Systems, Inc. was incorporated in 1987 and is headquartered in South Jordan, Utah.